Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide for weight management in overweight/obese Chinese adults (Phase 3)
CTR20210227Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2021
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of tirzepatide in Overweight, obesity, sponsored by Eli Lilly and Company. Started Feb 2021; status: completed.
02
Drugs
03
Conditions
Overweightobesity
Beyond the preview
Go deeper on CTR20210227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210227.